ID,Description,GeneRatio,BgRatio,pvalue,qvalue,geneID,Count
GO:0050673,epithelial cell proliferation,4/10,482/18888,7.78367615684454e-05,0.0115566234843158,CDH3/ERBB2/OSR1/ESR1,4
GO:0050679,positive regulation of epithelial cell proliferation,3/10,219/18888,0.00017374172594442,0.0115566234843158,CDH3/ERBB2/OSR1,3
GO:0008406,gonad development,3/10,233/18888,0.000208593260263289,0.0115566234843158,OSR1/ESR1/FOXC1,3
GO:0071364,cellular response to epidermal growth factor stimulus,2/10,42/18888,0.000214778040592576,0.0115566234843158,ERBB2/FOXC1,2
GO:0045137,development of primary sexual characteristics,3/10,238/18888,0.000222062194772127,0.0115566234843158,OSR1/ESR1/FOXC1,3
GO:0048863,stem cell differentiation,3/10,248/18888,0.000250672516822085,0.0115566234843158,OSR1/ESR1/FOXC1,3
GO:0070849,response to epidermal growth factor,2/10,46/18888,0.000257891094532552,0.0115566234843158,ERBB2/FOXC1,2
GO:0048762,mesenchymal cell differentiation,3/10,269/18888,0.000318324654167127,0.0117056783669503,FAM83D/OSR1/FOXC1,3
GO:0007548,sex differentiation,3/10,288/18888,0.000388868888511058,0.0117056783669503,OSR1/ESR1/FOXC1,3
GO:0001541,ovarian follicle development,2/10,57/18888,0.000396441705572768,0.0117056783669503,ESR1/FOXC1,2
GO:0072132,mesenchyme morphogenesis,2/10,58/18888,0.000410484358841041,0.0117056783669503,OSR1/FOXC1,2
GO:0048608,reproductive structure development,3/10,307/18888,0.000468826597794478,0.0117488669654218,OSR1/ESR1/FOXC1,3
GO:0061458,reproductive system development,3/10,311/18888,0.000486907741687783,0.0117488669654218,OSR1/ESR1/FOXC1,3
GO:0001655,urogenital system development,2/10,66/18888,0.00053145870557421,0.011907871748956,OSR1/ESR1,2
GO:0060485,mesenchyme development,3/10,336/18888,0.000610176002236217,0.0120539066859063,FAM83D/OSR1/FOXC1,3
GO:0032835,glomerulus development,2/10,71/18888,0.000614830139683811,0.0120539066859063,OSR1/FOXC1,2
GO:0050678,regulation of epithelial cell proliferation,3/10,407/18888,0.00106476178190236,0.0170571334120388,CDH3/ERBB2/OSR1,3
GO:0001657,ureteric bud development,2/10,99/18888,0.00119076032403685,0.0170571334120388,OSR1/FOXC1,2
GO:0072163,mesonephric epithelium development,2/10,100/18888,0.00121471828867294,0.0170571334120388,OSR1/FOXC1,2
GO:0072164,mesonephric tubule development,2/10,100/18888,0.00121471828867294,0.0170571334120388,OSR1/FOXC1,2
GO:0008585,female gonad development,2/10,102/18888,0.00126332910135928,0.0170571334120388,ESR1/FOXC1,2
GO:0035282,segmentation,2/10,103/18888,0.00128798154510171,0.0170571334120388,OSR1/FOXC1,2
GO:0001823,mesonephros development,2/10,104/18888,0.00131286507776158,0.0170571334120388,OSR1/FOXC1,2
GO:0046545,development of primary female sexual characteristics,2/10,106/18888,0.00136332460247052,0.0170571334120388,ESR1/FOXC1,2
GO:0009410,response to xenobiotic stimulus,3/10,444/18888,0.00136890673253433,0.0170571334120388,NAT1/CDH3/TYMS,3
GO:0048732,gland development,3/10,449/18888,0.00141379595730657,0.0170571334120388,TYMS/ESR1/FOXC1,3
GO:0046660,female sex differentiation,2/10,121/18888,0.00177104656652899,0.0198410480009639,ESR1/FOXC1,2
GO:0072009,nephron epithelium development,2/10,121/18888,0.00177104656652899,0.0198410480009639,OSR1/FOXC1,2
GO:0042476,odontogenesis,2/10,133/18888,0.00213410737378727,0.0230839926456844,OSR1/FOXC1,2
GO:0007498,mesoderm development,2/10,140/18888,0.00236088287837783,0.0246857227283016,OSR1/FOXC1,2
GO:0072073,kidney epithelium development,2/10,152/18888,0.00277510467732493,0.0268623329830211,OSR1/FOXC1,2
GO:0072006,nephron development,2/10,158/18888,0.00299418867556052,0.0268623329830211,OSR1/FOXC1,2
GO:0030856,regulation of epithelial cell differentiation,2/10,171/18888,0.00349600340598901,0.0268623329830211,OSR1/FOXC1,2
GO:0030216,keratinocyte differentiation,2/10,177/18888,0.00374004037187289,0.0268623329830211,CDH3/FOXC1,2
GO:0035265,organ growth,2/10,180/18888,0.00386498361181102,0.0268623329830211,ESR1/FOXC1,2
GO:0001837,epithelial to mesenchymal transition,2/10,187/18888,0.00416406443250613,0.0268623329830211,FAM83D/FOXC1,2
GO:0007369,gastrulation,2/10,200/18888,0.00474733844699834,0.0268623329830211,OSR1/FOXC1,2
GO:0051216,cartilage development,2/10,209/18888,0.00517215987608079,0.0268623329830211,TYMS/OSR1,2
GO:0033085,negative regulation of T cell differentiation in thymus,1/10,10/18888,0.0052830267288938,0.0268623329830211,ERBB2,1
GO:0038129,ERBB3 signaling pathway,1/10,10/18888,0.0052830267288938,0.0268623329830211,ERBB2,1
GO:0038130,ERBB4 signaling pathway,1/10,10/18888,0.0052830267288938,0.0268623329830211,ERBB2,1
GO:0048023,positive regulation of melanin biosynthetic process,1/10,10/18888,0.0052830267288938,0.0268623329830211,CDH3,1
GO:0048340,paraxial mesoderm morphogenesis,1/10,10/18888,0.0052830267288938,0.0268623329830211,FOXC1,1
GO:0060068,vagina development,1/10,10/18888,0.0052830267288938,0.0268623329830211,ESR1,1
GO:0060525,prostate glandular acinus development,1/10,10/18888,0.0052830267288938,0.0268623329830211,ESR1,1
GO:0072172,mesonephric tubule formation,1/10,10/18888,0.0052830267288938,0.0268623329830211,OSR1,1
GO:0072203,cell proliferation involved in metanephros development,1/10,10/18888,0.0052830267288938,0.0268623329830211,OSR1,1
GO:1900378,positive regulation of secondary metabolite biosynthetic process,1/10,10/18888,0.0052830267288938,0.0268623329830211,CDH3,1
GO:0002064,epithelial cell development,2/10,216/18888,0.00551436129729811,0.0268623329830211,TYMS/ESR1,2
GO:0009952,anterior/posterior pattern specification,2/10,219/18888,0.00566415763810244,0.0268623329830211,OSR1/FOXC1,2
GO:0009176,pyrimidine deoxyribonucleoside monophosphate metabolic process,1/10,11/18888,0.0058099453501842,0.0268623329830211,TYMS,1
GO:0044848,biological phase,1/10,11/18888,0.0058099453501842,0.0268623329830211,CDH3,1
GO:0051593,response to folic acid,1/10,11/18888,0.0058099453501842,0.0268623329830211,TYMS,1
GO:0060272,embryonic skeletal joint morphogenesis,1/10,11/18888,0.0058099453501842,0.0268623329830211,OSR1,1
GO:0060736,prostate gland growth,1/10,11/18888,0.0058099453501842,0.0268623329830211,ESR1,1
GO:0072178,nephric duct morphogenesis,1/10,11/18888,0.0058099453501842,0.0268623329830211,OSR1,1
GO:1904238,pericyte cell differentiation,1/10,11/18888,0.0058099453501842,0.0268623329830211,OSR1,1
GO:0048705,skeletal system morphogenesis,2/10,229/18888,0.0061769973711135,0.0268623329830211,OSR1/FOXC1,2
GO:0001547,antral ovarian follicle growth,1/10,12/18888,0.00633661275212771,0.0268623329830211,ESR1,1
GO:0033083,regulation of immature T cell proliferation,1/10,12/18888,0.00633661275212771,0.0268623329830211,ERBB2,1
GO:0033084,regulation of immature T cell proliferation in thymus,1/10,12/18888,0.00633661275212771,0.0268623329830211,ERBB2,1
GO:0060442,branching involved in prostate gland morphogenesis,1/10,12/18888,0.00633661275212771,0.0268623329830211,ESR1,1
GO:0072182,regulation of nephron tubule epithelial cell differentiation,1/10,12/18888,0.00633661275212771,0.0268623329830211,OSR1,1
GO:1902337,regulation of apoptotic process involved in morphogenesis,1/10,12/18888,0.00633661275212771,0.0268623329830211,FOXC1,1
GO:0033079,immature T cell proliferation,1/10,13/18888,0.00686302904119784,0.0268623329830211,ERBB2,1
GO:0033080,immature T cell proliferation in thymus,1/10,13/18888,0.00686302904119784,0.0268623329830211,ERBB2,1
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,1/10,13/18888,0.00686302904119784,0.0268623329830211,CDH3,1
GO:1904748,regulation of apoptotic process involved in development,1/10,13/18888,0.00686302904119784,0.0268623329830211,FOXC1,1
GO:0009913,epidermal cell differentiation,2/10,246/18888,0.00709612421301977,0.0268623329830211,CDH3/FOXC1,2
GO:0002069,columnar/cuboidal epithelial cell maturation,1/10,14/18888,0.00738919432382501,0.0268623329830211,TYMS,1
GO:0009263,deoxyribonucleotide biosynthetic process,1/10,14/18888,0.00738919432382501,0.0268623329830211,TYMS,1
GO:0009265,2'-deoxyribonucleotide biosynthetic process,1/10,14/18888,0.00738919432382501,0.0268623329830211,TYMS,1
GO:0046385,deoxyribose phosphate biosynthetic process,1/10,14/18888,0.00738919432382501,0.0268623329830211,TYMS,1
GO:0072075,metanephric mesenchyme development,1/10,14/18888,0.00738919432382501,0.0268623329830211,OSR1,1
GO:0072160,nephron tubule epithelial cell differentiation,1/10,14/18888,0.00738919432382501,0.0268623329830211,OSR1,1
GO:2000650,negative regulation of sodium ion transmembrane transporter activity,1/10,14/18888,0.00738919432382501,0.0268623329830211,OSR1,1
GO:0001894,tissue homeostasis,2/10,259/18888,0.00783868873815737,0.0268623329830211,CDH3/FOXC1,2
GO:0060249,anatomical structure homeostasis,2/10,259/18888,0.00783868873815737,0.0268623329830211,CDH3/FOXC1,2
GO:0009130,pyrimidine nucleoside monophosphate biosynthetic process,1/10,15/18888,0.00791510870640155,0.0268623329830211,TYMS,1
GO:0010838,positive regulation of keratinocyte proliferation,1/10,15/18888,0.00791510870640155,0.0268623329830211,CDH3,1
GO:0033189,response to vitamin A,1/10,15/18888,0.00791510870640155,0.0268623329830211,TYMS,1
GO:0048820,hair follicle maturation,1/10,15/18888,0.00791510870640155,0.0268623329830211,CDH3,1
GO:0072176,nephric duct development,1/10,15/18888,0.00791510870640155,0.0268623329830211,OSR1,1
GO:0072498,embryonic skeletal joint development,1/10,15/18888,0.00791510870640155,0.0268623329830211,OSR1,1
GO:1902306,negative regulation of sodium ion transmembrane transport,1/10,15/18888,0.00791510870640155,0.0268623329830211,OSR1,1
GO:0006206,pyrimidine nucleobase metabolic process,1/10,16/18888,0.00844077229528206,0.0268623329830211,TYMS,1
GO:0043455,regulation of secondary metabolic process,1/10,16/18888,0.00844077229528206,0.0268623329830211,CDH3,1
GO:0048021,regulation of melanin biosynthetic process,1/10,16/18888,0.00844077229528206,0.0268623329830211,CDH3,1
GO:1900376,regulation of secondary metabolite biosynthetic process,1/10,16/18888,0.00844077229528206,0.0268623329830211,CDH3,1
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,1/10,16/18888,0.00844077229528206,0.0268623329830211,OSR1,1
GO:0071695,anatomical structure maturation,2/10,271/18888,0.00855428383480707,0.0268623329830211,CDH3/TYMS,2
GO:0007379,segment specification,1/10,17/18888,0.00896618519677905,0.0268623329830211,OSR1,1
GO:0010470,regulation of gastrulation,1/10,17/18888,0.00896618519677905,0.0268623329830211,OSR1,1
GO:0034392,negative regulation of smooth muscle cell apoptotic process,1/10,17/18888,0.00896618519677905,0.0268623329830211,ESR1,1
GO:0072074,kidney mesenchyme development,1/10,17/18888,0.00896618519677905,0.0268623329830211,OSR1,1
GO:0072224,metanephric glomerulus development,1/10,17/18888,0.00896618519677905,0.0268623329830211,OSR1,1
GO:1902036,regulation of hematopoietic stem cell differentiation,1/10,17/18888,0.00896618519677905,0.0268623329830211,FOXC1,1
GO:0001946,lymphangiogenesis,1/10,18/18888,0.00949134751716674,0.0268623329830211,FOXC1,1
GO:0010766,negative regulation of sodium ion transport,1/10,18/18888,0.00949134751716674,0.0268623329830211,OSR1,1
GO:0060576,intestinal epithelial cell development,1/10,18/18888,0.00949134751716674,0.0268623329830211,TYMS,1
GO:0072087,renal vesicle development,1/10,18/18888,0.00949134751716674,0.0268623329830211,OSR1,1
GO:0072189,ureter development,1/10,18/18888,0.00949134751716674,0.0268623329830211,OSR1,1
GO:0061448,connective tissue development,2/10,288/18888,0.00961695655642766,0.0268623329830211,TYMS/OSR1,2
GO:0009148,pyrimidine nucleoside triphosphate biosynthetic process,1/10,19/18888,0.010016259362679,0.0268623329830211,TYMS,1
GO:0030540,female genitalia development,1/10,19/18888,0.010016259362679,0.0268623329830211,ESR1,1
GO:0045618,positive regulation of keratinocyte differentiation,1/10,19/18888,0.010016259362679,0.0268623329830211,FOXC1,1
GO:0046653,tetrahydrofolate metabolic process,1/10,19/18888,0.010016259362679,0.0268623329830211,TYMS,1
GO:0048339,paraxial mesoderm development,1/10,19/18888,0.010016259362679,0.0268623329830211,FOXC1,1
GO:0051797,regulation of hair follicle development,1/10,19/18888,0.010016259362679,0.0268623329830211,CDH3,1
GO:0060602,branch elongation of an epithelium,1/10,19/18888,0.010016259362679,0.0268623329830211,ESR1,1
GO:0048511,rhythmic process,2/10,297/18888,0.0102024936108358,0.0268623329830211,TYMS/ESR1,2
GO:0060749,mammary gland alveolus development,1/10,20/18888,0.0105409208395132,0.0268623329830211,ESR1,1
GO:0061377,mammary gland lobule development,1/10,20/18888,0.0105409208395132,0.0268623329830211,ESR1,1
GO:0071391,cellular response to estrogen stimulus,1/10,20/18888,0.0105409208395132,0.0268623329830211,ESR1,1
GO:0072079,nephron tubule formation,1/10,20/18888,0.0105409208395132,0.0268623329830211,OSR1,1
GO:2000679,positive regulation of transcription regulatory region DNA binding,1/10,20/18888,0.0105409208395132,0.0268623329830211,FOXC1,1
GO:0070372,regulation of ERK1 and ERK2 cascade,2/10,308/18888,0.0109394767526941,0.0268623329830211,ERBB2/FAM83D,2
GO:0009129,pyrimidine nucleoside monophosphate metabolic process,1/10,21/18888,0.0110653320538228,0.0268623329830211,TYMS,1
GO:0032402,melanosome transport,1/10,21/18888,0.0110653320538228,0.0268623329830211,CDH3,1
GO:0042474,middle ear morphogenesis,1/10,21/18888,0.0110653320538228,0.0268623329830211,OSR1,1
GO:2000738,positive regulation of stem cell differentiation,1/10,21/18888,0.0110653320538228,0.0268623329830211,FOXC1,1
GO:0098813,nuclear chromosome segregation,2/10,317/18888,0.011559755369141,0.0268623329830211,FAM83D/MYBL2,2
GO:0032401,establishment of melanosome localization,1/10,22/18888,0.0115894931117266,0.0268623329830211,CDH3,1
GO:0051904,pigment granule transport,1/10,22/18888,0.0115894931117266,0.0268623329830211,CDH3,1
GO:0060444,branching involved in mammary gland duct morphogenesis,1/10,22/18888,0.0115894931117266,0.0268623329830211,ESR1,1
GO:0072111,cell proliferation involved in kidney development,1/10,22/18888,0.0115894931117266,0.0268623329830211,OSR1,1
GO:0072234,metanephric nephron tubule development,1/10,22/18888,0.0115894931117266,0.0268623329830211,OSR1,1
GO:0043588,skin development,2/10,318/18888,0.0116296296264494,0.0268623329830211,CDH3/FOXC1,2
GO:0001822,kidney development,2/10,319/18888,0.0116996941103278,0.0268623329830211,OSR1/FOXC1,2
GO:0009162,deoxyribonucleoside monophosphate metabolic process,1/10,23/18888,0.0121134041192998,0.0268623329830211,TYMS,1
GO:0009219,pyrimidine deoxyribonucleotide metabolic process,1/10,23/18888,0.0121134041192998,0.0268623329830211,TYMS,1
GO:0036303,lymph vessel morphogenesis,1/10,23/18888,0.0121134041192998,0.0268623329830211,FOXC1,1
GO:0038128,ERBB2 signaling pathway,1/10,23/18888,0.0121134041192998,0.0268623329830211,ERBB2,1
GO:0040019,positive regulation of embryonic development,1/10,23/18888,0.0121134041192998,0.0268623329830211,OSR1,1
GO:0051905,establishment of pigment granule localization,1/10,23/18888,0.0121134041192998,0.0268623329830211,CDH3,1
GO:0072202,cell differentiation involved in metanephros development,1/10,23/18888,0.0121134041192998,0.0268623329830211,OSR1,1
GO:0072001,renal system development,2/10,329/18888,0.0124107621920322,0.0268623329830211,OSR1/FOXC1,2
GO:0070371,ERK1 and ERK2 cascade,2/10,332/18888,0.0126277619430951,0.0268623329830211,ERBB2/FAM83D,2
GO:0009147,pyrimidine nucleoside triphosphate metabolic process,1/10,24/18888,0.0126370651825811,0.0268623329830211,TYMS,1
GO:0032400,melanosome localization,1/10,24/18888,0.0126370651825811,0.0268623329830211,CDH3,1
GO:0042438,melanin biosynthetic process,1/10,24/18888,0.0126370651825811,0.0268623329830211,CDH3,1
GO:0060562,epithelial tube morphogenesis,2/10,335/18888,0.0128464513278392,0.0268623329830211,OSR1/ESR1,2
GO:0048545,response to steroid hormone,2/10,338/18888,0.0130668255686633,0.0268623329830211,TYMS/ESR1,2
GO:0002070,epithelial cell maturation,1/10,25/18888,0.0131604764075693,0.0268623329830211,TYMS,1
GO:0006582,melanin metabolic process,1/10,25/18888,0.0131604764075693,0.0268623329830211,CDH3,1
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,1/10,25/18888,0.0131604764075693,0.0268623329830211,CDH3,1
GO:0051875,pigment granule localization,1/10,25/18888,0.0131604764075693,0.0268623329830211,CDH3,1
GO:0060561,apoptotic process involved in morphogenesis,1/10,25/18888,0.0131604764075693,0.0268623329830211,FOXC1,1
GO:0072170,metanephric tubule development,1/10,25/18888,0.0131604764075693,0.0268623329830211,OSR1,1
GO:0072243,metanephric nephron epithelium development,1/10,25/18888,0.0131604764075693,0.0268623329830211,OSR1,1
GO:0099633,protein localization to postsynaptic specialization membrane,1/10,25/18888,0.0131604764075693,0.0268623329830211,ERBB2,1
GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,1/10,25/18888,0.0131604764075693,0.0268623329830211,ERBB2,1
GO:0021700,developmental maturation,2/10,341/18888,0.0132888798963065,0.0268623329830211,CDH3/TYMS,2
GO:0008045,motor neuron axon guidance,1/10,26/18888,0.0136836379002228,0.0268623329830211,ERBB2,1
GO:0033598,mammary gland epithelial cell proliferation,1/10,26/18888,0.0136836379002228,0.0268623329830211,ESR1,1
GO:0044550,secondary metabolite biosynthetic process,1/10,26/18888,0.0136836379002228,0.0268623329830211,CDH3,1
GO:0060065,uterus development,1/10,26/18888,0.0136836379002228,0.0268623329830211,ESR1,1
GO:0060740,prostate gland epithelium morphogenesis,1/10,26/18888,0.0136836379002228,0.0268623329830211,ESR1,1
GO:0072010,glomerular epithelium development,1/10,26/18888,0.0136836379002228,0.0268623329830211,FOXC1,1
GO:0045765,regulation of angiogenesis,2/10,353/18888,0.014193802981152,0.0268623329830211,ERBB2/FOXC1,2
GO:0033081,regulation of T cell differentiation in thymus,1/10,27/18888,0.0142065497664617,0.0268623329830211,ERBB2,1
GO:0048745,smooth muscle tissue development,1/10,27/18888,0.0142065497664617,0.0268623329830211,OSR1,1
GO:1902894,negative regulation of miRNA transcription,1/10,27/18888,0.0142065497664617,0.0268623329830211,ESR1,1
GO:0006760,folic acid-containing compound metabolic process,1/10,28/18888,0.0147292121121666,0.0268623329830211,TYMS,1
GO:0032770,positive regulation of monooxygenase activity,1/10,28/18888,0.0147292121121666,0.0268623329830211,CDH3,1
GO:0035116,embryonic hindlimb morphogenesis,1/10,28/18888,0.0147292121121666,0.0268623329830211,OSR1,1
GO:0042634,regulation of hair cycle,1/10,28/18888,0.0147292121121666,0.0268623329830211,CDH3,1
GO:0045606,positive regulation of epidermal cell differentiation,1/10,28/18888,0.0147292121121666,0.0268623329830211,FOXC1,1
GO:0060512,prostate gland morphogenesis,1/10,28/18888,0.0147292121121666,0.0268623329830211,ESR1,1
GO:0060575,intestinal epithelial cell differentiation,1/10,28/18888,0.0147292121121666,0.0268623329830211,TYMS,1
GO:0090314,positive regulation of protein targeting to membrane,1/10,28/18888,0.0147292121121666,0.0268623329830211,ERBB2,1
GO:2000629,negative regulation of miRNA metabolic process,1/10,28/18888,0.0147292121121666,0.0268623329830211,ESR1,1
GO:1901342,regulation of vasculature development,2/10,362/18888,0.0148899037492482,0.026998426025409,ERBB2/FOXC1,2
GO:0003401,axis elongation,1/10,29/18888,0.0152516250431783,0.0273382512052159,ESR1,1
GO:0072207,metanephric epithelium development,1/10,29/18888,0.0152516250431783,0.0273382512052159,OSR1,1
GO:0008209,androgen metabolic process,1/10,30/18888,0.0157737886652988,0.0276423935445989,ESR1,1
GO:0060603,mammary gland duct morphogenesis,1/10,30/18888,0.0157737886652988,0.0276423935445989,ESR1,1
GO:0072012,glomerulus vasculature development,1/10,30/18888,0.0157737886652988,0.0276423935445989,OSR1,1
GO:0097421,liver regeneration,1/10,30/18888,0.0157737886652988,0.0276423935445989,TYMS,1
GO:0001945,lymph vessel development,1/10,31/18888,0.0162957030842903,0.0283501315377933,FOXC1,1
GO:0001958,endochondral ossification,1/10,32/18888,0.0168173684058771,0.0283501315377933,FOXC1,1
GO:0006221,pyrimidine nucleotide biosynthetic process,1/10,32/18888,0.0168173684058771,0.0283501315377933,TYMS,1
GO:0036075,replacement ossification,1/10,32/18888,0.0168173684058771,0.0283501315377933,FOXC1,1
GO:0045684,positive regulation of epidermis development,1/10,32/18888,0.0168173684058771,0.0283501315377933,FOXC1,1
GO:0061437,renal system vasculature development,1/10,32/18888,0.0168173684058771,0.0283501315377933,OSR1,1
GO:0061440,kidney vasculature development,1/10,32/18888,0.0168173684058771,0.0283501315377933,OSR1,1
GO:0008544,epidermis development,2/10,387/18888,0.0169006740526476,0.0283501315377933,CDH3/FOXC1,2
GO:0034121,regulation of toll-like receptor signaling pathway,1/10,33/18888,0.0173387847357421,0.0285835969360918,ESR1,1
GO:0035115,embryonic forelimb morphogenesis,1/10,33/18888,0.0173387847357421,0.0285835969360918,OSR1,1
GO:0009112,nucleobase metabolic process,1/10,34/18888,0.0178599521795312,0.0285835969360918,TYMS,1
GO:0009954,proximal/distal pattern formation,1/10,34/18888,0.0178599521795312,0.0285835969360918,OSR1,1
GO:0010863,positive regulation of phospholipase C activity,1/10,34/18888,0.0178599521795312,0.0285835969360918,ESR1,1
GO:0042558,pteridine-containing compound metabolic process,1/10,34/18888,0.0178599521795312,0.0285835969360918,TYMS,1
GO:0090183,regulation of kidney development,1/10,34/18888,0.0178599521795312,0.0285835969360918,OSR1,1
GO:0090313,regulation of protein targeting to membrane,1/10,34/18888,0.0178599521795312,0.0285835969360918,ERBB2,1
GO:2000677,regulation of transcription regulatory region DNA binding,1/10,34/18888,0.0178599521795312,0.0285835969360918,FOXC1,1
GO:0045943,positive regulation of transcription by RNA polymerase I,1/10,35/18888,0.0183808708428498,0.0292679642595204,ERBB2,1
GO:0035137,hindlimb morphogenesis,1/10,36/18888,0.0189015408312636,0.0296455745669292,OSR1,1
GO:0060218,hematopoietic stem cell differentiation,1/10,36/18888,0.0189015408312636,0.0296455745669292,FOXC1,1
GO:1900274,regulation of phospholipase C activity,1/10,36/18888,0.0189015408312636,0.0296455745669292,ESR1,1
GO:0034391,regulation of smooth muscle cell apoptotic process,1/10,38/18888,0.0199421352054487,0.0308911143115769,ESR1,1
GO:0071392,cellular response to estradiol stimulus,1/10,38/18888,0.0199421352054487,0.0308911143115769,ESR1,1
GO:0007059,chromosome segregation,2/10,423/18888,0.0199911120637168,0.0308911143115769,FAM83D/MYBL2,2
GO:0034390,smooth muscle cell apoptotic process,1/10,39/18888,0.0204620598021568,0.0309583318409308,ESR1,1
GO:0035025,positive regulation of Rho protein signal transduction,1/10,39/18888,0.0204620598021568,0.0309583318409308,ERBB2,1
GO:0043388,positive regulation of DNA binding,1/10,39/18888,0.0204620598021568,0.0309583318409308,FOXC1,1
GO:0045616,regulation of keratinocyte differentiation,1/10,39/18888,0.0204620598021568,0.0309583318409308,FOXC1,1
GO:0003002,regionalization,2/10,429/18888,0.0205280750730467,0.0309583318409308,OSR1/FOXC1,2
GO:0006730,one-carbon metabolic process,1/10,40/18888,0.0209817361458342,0.0311926034994193,TYMS,1
GO:1901532,regulation of hematopoietic progenitor cell differentiation,1/10,40/18888,0.0209817361458342,0.0311926034994193,FOXC1,1
GO:1902742,apoptotic process involved in development,1/10,40/18888,0.0209817361458342,0.0311926034994193,FOXC1,1
GO:0060537,muscle tissue development,2/10,438/18888,0.0213450532770279,0.0312028018394817,OSR1/FOXC1,2
GO:0009394,2'-deoxyribonucleotide metabolic process,1/10,41/18888,0.0215011643418526,0.0312028018394817,TYMS,1
GO:0032570,response to progesterone,1/10,41/18888,0.0215011643418526,0.0312028018394817,TYMS,1
GO:0035136,forelimb morphogenesis,1/10,41/18888,0.0215011643418526,0.0312028018394817,OSR1,1
GO:0072210,metanephric nephron development,1/10,41/18888,0.0215011643418526,0.0312028018394817,OSR1,1
GO:0009124,nucleoside monophosphate biosynthetic process,1/10,42/18888,0.0220203444955415,0.0312028018394817,TYMS,1
GO:0009262,deoxyribonucleotide metabolic process,1/10,42/18888,0.0220203444955415,0.0312028018394817,TYMS,1
GO:0014044,Schwann cell development,1/10,42/18888,0.0220203444955415,0.0312028018394817,ERBB2,1
GO:0019692,deoxyribose phosphate metabolic process,1/10,42/18888,0.0220203444955415,0.0312028018394817,TYMS,1
GO:0072528,pyrimidine-containing compound biosynthetic process,1/10,42/18888,0.0220203444955415,0.0312028018394817,TYMS,1
GO:0001503,ossification,2/10,446/18888,0.0220827882817003,0.0312028018394817,OSR1/FOXC1,2
GO:0010518,positive regulation of phospholipase activity,1/10,43/18888,0.0225392767121946,0.0312981124260632,ESR1,1
GO:0032768,regulation of monooxygenase activity,1/10,43/18888,0.0225392767121946,0.0312981124260632,CDH3,1
GO:0051353,positive regulation of oxidoreductase activity,1/10,43/18888,0.0225392767121946,0.0312981124260632,CDH3,1
GO:0006417,regulation of translation,2/10,451/18888,0.0225493447579724,0.0312981124260632,ERBB2/TYMS,2
GO:0048568,embryonic organ development,2/10,455/18888,0.0229256037594908,0.0313113347319452,OSR1/FOXC1,2
GO:0030501,positive regulation of bone mineralization,1/10,44/18888,0.023057961097065,0.0313113347319452,OSR1,1
GO:0060443,mammary gland morphogenesis,1/10,44/18888,0.023057961097065,0.0313113347319452,ESR1,1
GO:0071526,semaphorin-plexin signaling pathway,1/10,44/18888,0.023057961097065,0.0313113347319452,ERBB2,1
GO:1903539,protein localization to postsynaptic membrane,1/10,44/18888,0.023057961097065,0.0313113347319452,ERBB2,1
GO:0010463,mesenchymal cell proliferation,1/10,45/18888,0.0235763977553661,0.031740530974019,OSR1,1
GO:0062237,protein localization to postsynapse,1/10,45/18888,0.0235763977553661,0.031740530974019,ERBB2,1
GO:0051656,establishment of organelle localization,2/10,472/18888,0.0245543368398355,0.0324393340877976,CDH3/FAM83D,2
GO:0010837,regulation of keratinocyte proliferation,1/10,47/18888,0.0246125283129229,0.0324393340877976,CDH3,1
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,1/10,47/18888,0.0246125283129229,0.0324393340877976,CDH3,1
GO:0048806,genitalia development,1/10,47/18888,0.0246125283129229,0.0324393340877976,ESR1,1
GO:0055010,ventricular cardiac muscle tissue morphogenesis,1/10,47/18888,0.0246125283129229,0.0324393340877976,FOXC1,1
GO:0007389,pattern specification process,2/10,474/18888,0.0247490827511455,0.0324401398391971,OSR1/FOXC1,2
GO:0006356,regulation of transcription by RNA polymerase I,1/10,48/18888,0.0251302224224116,0.0324401398391971,ERBB2,1
GO:0035850,epithelial cell differentiation involved in kidney development,1/10,48/18888,0.0251302224224116,0.0324401398391971,OSR1,1
GO:0044331,cell-cell adhesion mediated by cadherin,1/10,48/18888,0.0251302224224116,0.0324401398391971,CDH3,1
GO:0046189,phenol-containing compound biosynthetic process,1/10,48/18888,0.0251302224224116,0.0324401398391971,CDH3,1
GO:0014037,Schwann cell differentiation,1/10,49/18888,0.0256476692257966,0.0324406002940891,ERBB2,1
GO:0030850,prostate gland development,1/10,49/18888,0.0256476692257966,0.0324406002940891,ESR1,1
GO:0035272,exocrine system development,1/10,49/18888,0.0256476692257966,0.0324406002940891,FOXC1,1
GO:0045581,negative regulation of T cell differentiation,1/10,49/18888,0.0256476692257966,0.0324406002940891,ERBB2,1
GO:2000649,regulation of sodium ion transmembrane transporter activity,1/10,49/18888,0.0256476692257966,0.0324406002940891,OSR1,1
GO:0022602,ovulation cycle process,1/10,50/18888,0.0261648688280973,0.0329618723769732,ESR1,1
GO:0001974,blood vessel remodeling,1/10,51/18888,0.0266818213342929,0.0334786642426075,FOXC1,1
GO:0010517,regulation of phospholipase activity,1/10,52/18888,0.0271985268493251,0.0336967183699402,ESR1,1
GO:0002066,columnar/cuboidal epithelial cell development,1/10,53/18888,0.0277149854780951,0.0336967183699402,TYMS,1
GO:0006220,pyrimidine nucleotide metabolic process,1/10,53/18888,0.0277149854780951,0.0336967183699402,TYMS,1
GO:0038084,vascular endothelial growth factor signaling pathway,1/10,53/18888,0.0277149854780951,0.0336967183699402,FOXC1,1
GO:0045778,positive regulation of ossification,1/10,53/18888,0.0277149854780951,0.0336967183699402,OSR1,1
GO:0048009,insulin-like growth factor receptor signaling pathway,1/10,53/18888,0.0277149854780951,0.0336967183699402,CDH3,1
GO:0060193,positive regulation of lipase activity,1/10,53/18888,0.0277149854780951,0.0336967183699402,ESR1,1
GO:0060688,regulation of morphogenesis of a branching structure,1/10,53/18888,0.0277149854780951,0.0336967183699402,ESR1,1
GO:0010656,negative regulation of muscle cell apoptotic process,1/10,54/18888,0.0282311973254654,0.0338003085696613,ESR1,1
GO:0030520,intracellular estrogen receptor signaling pathway,1/10,54/18888,0.0282311973254654,0.0338003085696613,ESR1,1
GO:0048146,positive regulation of fibroblast proliferation,1/10,54/18888,0.0282311973254654,0.0338003085696613,ESR1,1
GO:0070169,positive regulation of biomineral tissue development,1/10,54/18888,0.0282311973254654,0.0338003085696613,OSR1,1
GO:0001895,retina homeostasis,1/10,55/18888,0.0287471624962595,0.034157314289814,CDH3,1
GO:0030857,negative regulation of epithelial cell differentiation,1/10,55/18888,0.0287471624962595,0.034157314289814,OSR1,1
GO:0007528,neuromuscular junction development,1/10,56/18888,0.0292628810952633,0.0346388820909175,ERBB2,1
GO:0019748,secondary metabolic process,1/10,57/18888,0.0297783532272221,0.0347249041741819,CDH3,1
GO:0034332,adherens junction organization,1/10,57/18888,0.0297783532272221,0.0347249041741819,CDH3,1
GO:0046148,pigment biosynthetic process,1/10,57/18888,0.0297783532272221,0.0347249041741819,CDH3,1
GO:0072698,protein localization to microtubule cytoskeleton,1/10,57/18888,0.0297783532272221,0.0347249041741819,FAM83D,1
GO:0042733,embryonic digit morphogenesis,1/10,58/18888,0.0302935789968426,0.0347631595441897,OSR1,1
GO:0061005,cell differentiation involved in kidney development,1/10,58/18888,0.0302935789968426,0.0347631595441897,OSR1,1
GO:0003229,ventricular cardiac muscle tissue development,1/10,59/18888,0.0308085585087936,0.0347631595441897,FOXC1,1
GO:0010718,positive regulation of epithelial to mesenchymal transition,1/10,59/18888,0.0308085585087936,0.0347631595441897,FOXC1,1
GO:0043616,keratinocyte proliferation,1/10,59/18888,0.0308085585087936,0.0347631595441897,CDH3,1
GO:0045604,regulation of epidermal cell differentiation,1/10,59/18888,0.0308085585087936,0.0347631595441897,FOXC1,1
GO:0045620,negative regulation of lymphocyte differentiation,1/10,59/18888,0.0308085585087936,0.0347631595441897,ERBB2,1
GO:0060135,maternal process involved in female pregnancy,1/10,59/18888,0.0308085585087936,0.0347631595441897,ESR1,1
GO:1902305,regulation of sodium ion transmembrane transport,1/10,59/18888,0.0308085585087936,0.0347631595441897,OSR1,1
GO:0060038,cardiac muscle cell proliferation,1/10,60/18888,0.031323291867703,0.0349666266213729,FOXC1,1
GO:0060350,endochondral bone morphogenesis,1/10,60/18888,0.031323291867703,0.0349666266213729,FOXC1,1
GO:0071168,protein localization to chromatin,1/10,60/18888,0.031323291867703,0.0349666266213729,ESR1,1
GO:0044380,protein localization to cytoskeleton,1/10,61/18888,0.0318377791781622,0.0351655233324401,FAM83D,1
GO:0048010,vascular endothelial growth factor receptor signaling pathway,1/10,61/18888,0.0318377791781622,0.0351655233324401,FOXC1,1
GO:0055008,cardiac muscle tissue morphogenesis,1/10,61/18888,0.0318377791781622,0.0351655233324401,FOXC1,1
GO:0097120,receptor localization to synapse,1/10,62/18888,0.0323520205447221,0.0356081334157975,ERBB2,1
GO:0033059,cellular pigmentation,1/10,63/18888,0.0328660160718947,0.0360473786876136,CDH3,1
GO:0043124,negative regulation of canonical NF-kappaB signal transduction,1/10,64/18888,0.0333797658641541,0.0364832944343222,ESR1,1
GO:0045682,regulation of epidermis development,1/10,65/18888,0.0338932700259345,0.0367881787205553,FOXC1,1
GO:1905330,regulation of morphogenesis of an epithelium,1/10,65/18888,0.0338932700259345,0.0367881787205553,ESR1,1
GO:0001756,somitogenesis,1/10,66/18888,0.0344065286616325,0.0369615917129289,FOXC1,1
GO:0030199,collagen fibril organization,1/10,66/18888,0.0344065286616325,0.0369615917129289,FOXC1,1
GO:0031100,animal organ regeneration,1/10,66/18888,0.0344065286616325,0.0369615917129289,TYMS,1
GO:0061180,mammary gland epithelium development,1/10,67/18888,0.0349195418756049,0.0373846720996237,ESR1,1
GO:0051123,RNA polymerase II preinitiation complex assembly,1/10,68/18888,0.0354323097721693,0.0374227478720767,ESR1,1
GO:0071300,cellular response to retinoic acid,1/10,68/18888,0.0354323097721693,0.0374227478720767,OSR1,1
GO:0072171,mesonephric tubule morphogenesis,1/10,68/18888,0.0354323097721693,0.0374227478720767,OSR1,1
GO:1902808,positive regulation of cell cycle G1/S phase transition,1/10,68/18888,0.0354323097721693,0.0374227478720767,FAM83D,1
GO:0043525,positive regulation of neuron apoptotic process,1/10,69/18888,0.035944832455606,0.0377101217101587,MYBL2,1
GO:0060191,regulation of lipase activity,1/10,69/18888,0.035944832455606,0.0377101217101587,ESR1,1
GO:0043627,response to estrogen,1/10,70/18888,0.0364571100301553,0.0381200659262676,ESR1,1
GO:0003208,cardiac ventricle morphogenesis,1/10,71/18888,0.0369691426000193,0.0385270309313018,FOXC1,1
GO:0032413,negative regulation of ion transmembrane transporter activity,1/10,72/18888,0.0374809302693605,0.0386749211228166,OSR1,1
GO:0042698,ovulation cycle,1/10,72/18888,0.0374809302693605,0.0386749211228166,ESR1,1
GO:0051341,regulation of oxidoreductase activity,1/10,72/18888,0.0374809302693605,0.0386749211228166,CDH3,1
GO:0006360,transcription by RNA polymerase I,1/10,73/18888,0.037992473142304,0.0386936329337204,ERBB2,1
GO:0030858,positive regulation of epithelial cell differentiation,1/10,73/18888,0.037992473142304,0.0386936329337204,FOXC1,1
GO:0042130,negative regulation of T cell proliferation,1/10,73/18888,0.037992473142304,0.0386936329337204,ERBB2,1
GO:0090307,mitotic spindle assembly,1/10,73/18888,0.037992473142304,0.0386936329337204,MYBL2,1
GO:0060415,muscle tissue morphogenesis,1/10,74/18888,0.0385037713229354,0.039087459902009,FOXC1,1
GO:1902893,regulation of miRNA transcription,1/10,75/18888,0.0390148249153015,0.0392359724815997,ESR1,1
GO:0001707,mesoderm formation,1/10,76/18888,0.0395256340234101,0.0392359724815997,FOXC1,1
GO:0002224,toll-like receptor signaling pathway,1/10,76/18888,0.0395256340234101,0.0392359724815997,ESR1,1
GO:0009123,nucleoside monophosphate metabolic process,1/10,76/18888,0.0395256340234101,0.0392359724815997,TYMS,1
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1/10,76/18888,0.0395256340234101,0.0392359724815997,FOXC1,1
GO:0051057,positive regulation of small GTPase mediated signal transduction,1/10,76/18888,0.0395256340234101,0.0392359724815997,ERBB2,1
GO:0061614,miRNA transcription,1/10,76/18888,0.0395256340234101,0.0392359724815997,ESR1,1
GO:0072078,nephron tubule morphogenesis,1/10,77/18888,0.0400361987512309,0.0396174239676799,OSR1,1
GO:0035418,protein localization to synapse,1/10,78/18888,0.0405465192026946,0.039746258955273,ERBB2,1
GO:0048332,mesoderm morphogenesis,1/10,78/18888,0.0405465192026946,0.039746258955273,FOXC1,1
GO:0051101,regulation of DNA binding,1/10,78/18888,0.0405465192026946,0.039746258955273,FOXC1,1
GO:0072088,nephron epithelium morphogenesis,1/10,79/18888,0.0410565954816939,0.0399962911197934,OSR1,1
GO:1903533,regulation of protein targeting,1/10,79/18888,0.0410565954816939,0.0399962911197934,ERBB2,1
GO:0014032,neural crest cell development,1/10,80/18888,0.0415664276920814,0.040117270034959,FOXC1,1
GO:0042440,pigment metabolic process,1/10,80/18888,0.0415664276920814,0.040117270034959,CDH3,1
GO:0003151,outflow tract morphogenesis,1/10,81/18888,0.0420760159376726,0.040117270034959,FOXC1,1
GO:0048644,muscle organ morphogenesis,1/10,81/18888,0.0420760159376726,0.040117270034959,FOXC1,1
GO:0048844,artery morphogenesis,1/10,81/18888,0.0420760159376726,0.040117270034959,FOXC1,1
GO:0061333,renal tubule morphogenesis,1/10,81/18888,0.0420760159376726,0.040117270034959,OSR1,1
GO:0072028,nephron morphogenesis,1/10,81/18888,0.0420760159376726,0.040117270034959,OSR1,1
GO:0030500,regulation of bone mineralization,1/10,82/18888,0.0425853603222438,0.0402360094357281,OSR1,1
GO:0043406,positive regulation of MAP kinase activity,1/10,82/18888,0.0425853603222438,0.0402360094357281,ERBB2,1
GO:0070897,transcription preinitiation complex assembly,1/10,82/18888,0.0425853603222438,0.0402360094357281,ESR1,1
GO:0031424,keratinization,1/10,83/18888,0.0430944609495317,0.0404732094641048,CDH3,1
GO:2000736,regulation of stem cell differentiation,1/10,83/18888,0.0430944609495317,0.0404732094641048,FOXC1,1
GO:0002028,regulation of sodium ion transport,1/10,84/18888,0.0436033179232352,0.0405865648637329,OSR1,1
GO:0014855,striated muscle cell proliferation,1/10,84/18888,0.0436033179232352,0.0405865648637329,FOXC1,1
GO:0072527,pyrimidine-containing compound metabolic process,1/10,84/18888,0.0436033179232352,0.0405865648637329,TYMS,1
GO:0061053,somite development,1/10,85/18888,0.0441119313470161,0.0409385099389934,FOXC1,1
GO:0035050,embryonic heart tube development,1/10,86/18888,0.0446203013244947,0.0411667176306484,FOXC1,1
GO:0048864,stem cell development,1/10,86/18888,0.0446203013244947,0.0411667176306484,FOXC1,1
GO:0033077,T cell differentiation in thymus,1/10,87/18888,0.0451284279592544,0.0415134172923532,ERBB2,1
GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,1/10,88/18888,0.0456363113548405,0.0418578663703985,ERBB2,1
GO:0035023,regulation of Rho protein signal transduction,1/10,89/18888,0.0461439516147579,0.0420252211009067,ERBB2,1
GO:0050672,negative regulation of lymphocyte proliferation,1/10,89/18888,0.0461439516147579,0.0420252211009067,ERBB2,1
GO:0007422,peripheral nervous system development,1/10,90/18888,0.0466513488424748,0.0420252211009067,ERBB2,1
GO:0032945,negative regulation of mononuclear cell proliferation,1/10,90/18888,0.0466513488424748,0.0420252211009067,ERBB2,1
GO:0048145,regulation of fibroblast proliferation,1/10,90/18888,0.0466513488424748,0.0420252211009067,ESR1,1
GO:2000628,regulation of miRNA metabolic process,1/10,90/18888,0.0466513488424748,0.0420252211009067,ESR1,1
GO:0010660,regulation of muscle cell apoptotic process,1/10,91/18888,0.0471585031414201,0.0420252211009067,ESR1,1
GO:0033273,response to vitamin,1/10,91/18888,0.0471585031414201,0.0420252211009067,TYMS,1
GO:0055017,cardiac muscle tissue growth,1/10,91/18888,0.0471585031414201,0.0420252211009067,FOXC1,1
GO:0060021,roof of mouth development,1/10,91/18888,0.0471585031414201,0.0420252211009067,OSR1,1
GO:0045995,regulation of embryonic development,1/10,92/18888,0.0476654146149843,0.0422089998330574,OSR1,1
GO:1904063,negative regulation of cation transmembrane transport,1/10,92/18888,0.0476654146149843,0.0422089998330574,OSR1,1
GO:0001656,metanephros development,1/10,93/18888,0.0481720833665196,0.0422089998330574,OSR1,1
GO:0014033,neural crest cell differentiation,1/10,93/18888,0.0481720833665196,0.0422089998330574,FOXC1,1
GO:0042475,odontogenesis of dentin-containing tooth,1/10,93/18888,0.0481720833665196,0.0422089998330574,FOXC1,1
GO:0070098,chemokine-mediated signaling pathway,1/10,93/18888,0.0481720833665196,0.0422089998330574,FOXC1,1
GO:0001942,hair follicle development,1/10,94/18888,0.0486785094993383,0.0424157772830491,CDH3,1
GO:0048704,embryonic skeletal system morphogenesis,1/10,94/18888,0.0486785094993383,0.0424157772830491,OSR1,1
GO:0032410,negative regulation of transporter activity,1/10,96/18888,0.0496906343218909,0.0431777490244161,OSR1,1
GO:0022404,molting cycle process,1/10,97/18888,0.0501963332180583,0.0432576844967651,CDH3,1
GO:0022405,hair cycle process,1/10,97/18888,0.0501963332180583,0.0432576844967651,CDH3,1
GO:0140747,regulation of ncRNA transcription,1/10,97/18888,0.0501963332180583,0.0432576844967651,ESR1,1
GO:0010657,muscle cell apoptotic process,1/10,98/18888,0.050701789908379,0.043336106102673,ESR1,1
GO:0060993,kidney morphogenesis,1/10,98/18888,0.050701789908379,0.043336106102673,OSR1,1
GO:0070664,negative regulation of leukocyte proliferation,1/10,98/18888,0.050701789908379,0.043336106102673,ERBB2,1
GO:0060349,bone morphogenesis,1/10,99/18888,0.0512070044959739,0.0435307012973905,FOXC1,1
GO:0060419,heart growth,1/10,99/18888,0.0512070044959739,0.0435307012973905,FOXC1,1
GO:0034766,negative regulation of monoatomic ion transmembrane transport,1/10,100/18888,0.0517119770839269,0.0436054588879746,OSR1,1
GO:0051310,metaphase chromosome alignment,1/10,100/18888,0.0517119770839269,0.0436054588879746,FAM83D,1
GO:0072080,nephron tubule development,1/10,100/18888,0.0517119770839269,0.0436054588879746,OSR1,1
GO:1990868,response to chemokine,1/10,101/18888,0.0522167077752805,0.0437956062961824,FOXC1,1
GO:1990869,cellular response to chemokine,1/10,101/18888,0.0522167077752805,0.0437956062961824,FOXC1,1
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,1/10,102/18888,0.0527211966730425,0.0439835291393244,ESR1,1
GO:0046620,regulation of organ growth,1/10,102/18888,0.0527211966730425,0.0439835291393244,FOXC1,1
GO:0070167,regulation of biomineral tissue development,1/10,103/18888,0.0532254438801795,0.0442864226617157,OSR1,1
GO:0061326,renal tubule development,1/10,104/18888,0.0537294494996201,0.044469867937472,OSR1,1
GO:1990830,cellular response to leukemia inhibitory factor,1/10,104/18888,0.0537294494996201,0.044469867937472,MYBL2,1
GO:0021549,cerebellum development,1/10,105/18888,0.0542332136342562,0.044651188459755,FOXC1,1
GO:1905477,positive regulation of protein localization to membrane,1/10,105/18888,0.0542332136342562,0.044651188459755,ERBB2,1
GO:0032526,response to retinoic acid,1/10,106/18888,0.0547367363869397,0.0447136717195944,OSR1,1
GO:0048709,oligodendrocyte differentiation,1/10,106/18888,0.0547367363869397,0.0447136717195944,ERBB2,1
GO:1990823,response to leukemia inhibitory factor,1/10,106/18888,0.0547367363869397,0.0447136717195944,MYBL2,1
GO:0010586,miRNA metabolic process,1/10,108/18888,0.0557430581576681,0.0452997854676441,ESR1,1
GO:1902414,protein localization to cell junction,1/10,108/18888,0.0557430581576681,0.0452997854676441,ERBB2,1
GO:0007173,epidermal growth factor receptor signaling pathway,1/10,110/18888,0.0567484156338594,0.0458790772080578,ERBB2,1
GO:0048144,fibroblast proliferation,1/10,110/18888,0.0567484156338594,0.0458790772080578,ESR1,1
GO:0030203,glycosaminoglycan metabolic process,1/10,111/18888,0.057250733018227,0.0460478230483985,FOXC1,1
GO:0090263,positive regulation of canonical Wnt signaling pathway,1/10,111/18888,0.057250733018227,0.0460478230483985,CDH3,1
GO:0051303,establishment of chromosome localization,1/10,112/18888,0.0577528096369534,0.0462146543281743,FAM83D,1
GO:1902106,negative regulation of leukocyte differentiation,1/10,112/18888,0.0577528096369534,0.0462146543281743,ERBB2,1
GO:0018958,phenol-containing compound metabolic process,1/10,113/18888,0.0582546455926217,0.0463796002848017,CDH3,1
GO:0060840,artery development,1/10,113/18888,0.0582546455926217,0.0463796002848017,FOXC1,1
GO:0043473,pigmentation,1/10,114/18888,0.0587562409877789,0.0465868977328317,CDH3,1
GO:0022037,metencephalon development,1/10,115/18888,0.0592575959249324,0.0465868977328317,FOXC1,1
GO:0032355,response to estradiol,1/10,115/18888,0.0592575959249324,0.0465868977328317,ESR1,1
GO:0051099,positive regulation of binding,1/10,115/18888,0.0592575959249324,0.0465868977328317,FOXC1,1
GO:1904035,regulation of epithelial cell apoptotic process,1/10,115/18888,0.0592575959249324,0.0465868977328317,ESR1,1
GO:0002062,chondrocyte differentiation,1/10,116/18888,0.0597587105065521,0.0468634098182961,OSR1,1
GO:1901989,positive regulation of cell cycle phase transition,1/10,117/18888,0.0602595848350702,0.0471383548519515,FAM83D,1
GO:0042303,molting cycle,1/10,118/18888,0.060760219012879,0.0472940975991588,CDH3,1
GO:0042633,hair cycle,1/10,118/18888,0.060760219012879,0.0472940975991588,CDH3,1
GO:1903707,negative regulation of hemopoiesis,1/10,119/18888,0.0612606131423341,0.0475655620542355,ERBB2,1
GO:0010717,regulation of epithelial to mesenchymal transition,1/10,120/18888,0.061760767325752,0.0477176786701428,FOXC1,1
GO:0050000,chromosome localization,1/10,120/18888,0.061760767325752,0.0477176786701428,FAM83D,1
GO:0006022,aminoglycan metabolic process,1/10,122/18888,0.0627603562635554,0.0479000798221014,FOXC1,1
GO:0030278,regulation of ossification,1/10,122/18888,0.0627603562635554,0.0479000798221014,OSR1,1
GO:0030326,embryonic limb morphogenesis,1/10,122/18888,0.0627603562635554,0.0479000798221014,OSR1,1
GO:0035113,embryonic appendage morphogenesis,1/10,122/18888,0.0627603562635554,0.0479000798221014,OSR1,1
GO:0045471,response to ethanol,1/10,122/18888,0.0627603562635554,0.0479000798221014,TYMS,1
GO:0001838,embryonic epithelial tube formation,1/10,123/18888,0.0632597912223828,0.0480474519797886,OSR1,1
GO:0030518,intracellular steroid hormone receptor signaling pathway,1/10,123/18888,0.0632597912223828,0.0480474519797886,ESR1,1
GO:0034502,protein localization to chromosome,1/10,124/18888,0.0637589866440606,0.0482771368886891,ESR1,1
GO:0002065,columnar/cuboidal epithelial cell differentiation,1/10,125/18888,0.0642579426307132,0.0482771368886891,TYMS,1
GO:0022612,gland morphogenesis,1/10,125/18888,0.0642579426307132,0.0482771368886891,ESR1,1
GO:0006805,xenobiotic metabolic process,1/10,126/18888,0.0647566592844303,0.0482771368886891,NAT1,1
GO:0009142,nucleoside triphosphate biosynthetic process,1/10,126/18888,0.0647566592844303,0.0482771368886891,TYMS,1
GO:0003206,cardiac chamber morphogenesis,1/10,127/18888,0.0652551367072616,0.0482771368886891,FOXC1,1
GO:0003231,cardiac ventricle development,1/10,127/18888,0.0652551367072616,0.0482771368886891,FOXC1,1
GO:0030282,bone mineralization,1/10,127/18888,0.0652551367072616,0.0482771368886891,OSR1,1
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,1/10,127/18888,0.0652551367072616,0.0482771368886891,CDH3,1
GO:0042471,ear morphogenesis,1/10,127/18888,0.0652551367072616,0.0482771368886891,OSR1,1
GO:0071902,positive regulation of protein serine/threonine kinase activity,1/10,127/18888,0.0652551367072616,0.0482771368886891,ERBB2,1
GO:0006612,protein targeting to membrane,1/10,128/18888,0.0657533750012186,0.04830397078852,ERBB2,1
GO:0046683,response to organophosphorus,1/10,128/18888,0.0657533750012186,0.04830397078852,TYMS,1
GO:0048706,embryonic skeletal system development,1/10,128/18888,0.0657533750012186,0.04830397078852,OSR1,1
GO:0050868,negative regulation of T cell activation,1/10,129/18888,0.0662513742682755,0.048330255892157,ERBB2,1
GO:0051225,spindle assembly,1/10,129/18888,0.0662513742682755,0.048330255892157,MYBL2,1
GO:0098773,skin epidermis development,1/10,129/18888,0.0662513742682755,0.048330255892157,CDH3,1
GO:0001704,formation of primary germ layer,1/10,131/18888,0.0672466561293946,0.0487164301119718,FOXC1,1
GO:0007052,mitotic spindle organization,1/10,131/18888,0.0672466561293946,0.0487164301119718,MYBL2,1
GO:0038127,ERBB signaling pathway,1/10,131/18888,0.0672466561293946,0.0487164301119718,ERBB2,1
GO:0002244,hematopoietic progenitor cell differentiation,1/10,133/18888,0.0682409831056491,0.0489842538009959,FOXC1,1
GO:0021782,glial cell development,1/10,133/18888,0.0682409831056491,0.0489842538009959,ERBB2,1
GO:0043271,negative regulation of monoatomic ion transport,1/10,133/18888,0.0682409831056491,0.0489842538009959,OSR1,1
GO:0048565,digestive tract development,1/10,133/18888,0.0682409831056491,0.0489842538009959,TYMS,1
GO:0043405,regulation of MAP kinase activity,1/10,134/18888,0.0687377887664838,0.0490044522784981,ERBB2,1
GO:0045727,positive regulation of translation,1/10,134/18888,0.0687377887664838,0.0490044522784981,ERBB2,1
GO:0051384,response to glucocorticoid,1/10,134/18888,0.0687377887664838,0.0490044522784981,TYMS,1
GO:0030879,mammary gland development,1/10,135/18888,0.0692343560114623,0.049135122865958,ESR1,1
GO:0072175,epithelial tube formation,1/10,135/18888,0.0692343560114623,0.049135122865958,OSR1,1
GO:0043401,steroid hormone mediated signaling pathway,1/10,139/18888,0.071218242866414,0.050428980335491,ESR1,1
GO:0001889,liver development,1/10,143/18888,0.0731983231974774,0.0517143203244388,TYMS,1
GO:0034763,negative regulation of transmembrane transport,1/10,144/18888,0.0736927492720589,0.0519428288427756,OSR1,1
GO:0007266,Rho protein signal transduction,1/10,145/18888,0.0741869379461562,0.0519428288427756,ERBB2,1
GO:0032006,regulation of TOR signaling,1/10,145/18888,0.0741869379461562,0.0519428288427756,FAM83D,1
GO:0055123,digestive system development,1/10,145/18888,0.0741869379461562,0.0519428288427756,TYMS,1
GO:0030177,positive regulation of Wnt signaling pathway,1/10,146/18888,0.0746808893210981,0.0519428288427756,CDH3,1
GO:0061008,hepaticobiliary system development,1/10,146/18888,0.0746808893210981,0.0519428288427756,TYMS,1
GO:0098781,ncRNA transcription,1/10,146/18888,0.0746808893210981,0.0519428288427756,ESR1,1
GO:1904019,epithelial cell apoptotic process,1/10,147/18888,0.0751746034981755,0.0521705445795443,ESR1,1
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/10,148/18888,0.0756680805786417,0.0522722849168418,ERBB2,1
GO:0006367,transcription initiation at RNA polymerase II promoter,1/10,149/18888,0.0761613206637123,0.0522722849168418,ESR1,1
GO:0008584,male gonad development,1/10,149/18888,0.0761613206637123,0.0522722849168418,ESR1,1
GO:0035148,tube formation,1/10,149/18888,0.0761613206637123,0.0522722849168418,OSR1,1
GO:0016331,morphogenesis of embryonic epithelium,1/10,150/18888,0.0766543238545633,0.0522722849168418,OSR1,1
GO:0035107,appendage morphogenesis,1/10,150/18888,0.0766543238545633,0.0522722849168418,OSR1,1
GO:0035108,limb morphogenesis,1/10,150/18888,0.0766543238545633,0.0522722849168418,OSR1,1
GO:0046546,development of primary male sexual characteristics,1/10,150/18888,0.0766543238545633,0.0522722849168418,ESR1,1
GO:0035296,regulation of tube diameter,1/10,152/18888,0.0776396199581302,0.0527149846149984,FOXC1,1
GO:0097746,blood vessel diameter maintenance,1/10,152/18888,0.0776396199581302,0.0527149846149984,FOXC1,1
GO:0016525,negative regulation of angiogenesis,1/10,153/18888,0.0781319130730116,0.052820576442281,FOXC1,1
GO:0035150,regulation of tube size,1/10,153/18888,0.0781319130730116,0.052820576442281,FOXC1,1
GO:0042552,myelination,1/10,154/18888,0.0786239696980058,0.0530182085527109,ERBB2,1
GO:2000181,negative regulation of blood vessel morphogenesis,1/10,155/18888,0.0791157899341021,0.0530182085527109,FOXC1,1
GO:0007043,cell-cell junction assembly,1/10,156/18888,0.07960737388225,0.0530182085527109,CDH3,1
GO:0007272,ensheathment of neurons,1/10,156/18888,0.07960737388225,0.0530182085527109,ERBB2,1
GO:0008366,axon ensheathment,1/10,156/18888,0.07960737388225,0.0530182085527109,ERBB2,1
GO:0031960,response to corticosteroid,1/10,156/18888,0.07960737388225,0.0530182085527109,TYMS,1
GO:0043433,negative regulation of DNA-binding transcription factor activity,1/10,156/18888,0.07960737388225,0.0530182085527109,ESR1,1
GO:0048754,branching morphogenesis of an epithelial tube,1/10,157/18888,0.0800987216433636,0.0531198821625066,ESR1,1
GO:1901343,negative regulation of vasculature development,1/10,157/18888,0.0800987216433636,0.0531198821625066,FOXC1,1
GO:0030902,hindbrain development,1/10,158/18888,0.0805898333183175,0.053332823293046,FOXC1,1
GO:0030307,positive regulation of cell growth,1/10,163/18888,0.0830418539286981,0.0547246184669439,ERBB2,1
GO:0034250,positive regulation of amide metabolic process,1/10,163/18888,0.0830418539286981,0.0547246184669439,ERBB2,1
GO:0007584,response to nutrient,1/10,164/18888,0.0835315512029686,0.0548170056341877,TYMS,1
GO:1902850,microtubule cytoskeleton organization involved in mitosis,1/10,164/18888,0.0835315512029686,0.0548170056341877,MYBL2,1
GO:0031929,TOR signaling,1/10,165/18888,0.0840210130961518,0.0549084690847659,FAM83D,1
GO:0051250,negative regulation of lymphocyte activation,1/10,165/18888,0.0840210130961518,0.0549084690847659,ERBB2,1
GO:0062207,regulation of pattern recognition receptor signaling pathway,1/10,166/18888,0.084510239708823,0.0551133634603989,ESR1,1
GO:0003205,cardiac chamber development,1/10,168/18888,0.0854879874947353,0.0555201487924837,FOXC1,1
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,1/10,168/18888,0.0854879874947353,0.0555201487924837,CDH3,1
GO:0007204,positive regulation of cytosolic calcium ion concentration,1/10,169/18888,0.0859765088689369,0.0557220522900026,ESR1,1
GO:0046661,male sex differentiation,1/10,173/18888,0.0879282465834949,0.0568694899226945,ESR1,1
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,1/10,177/18888,0.08987623266094,0.0580097841303013,CDH3,1
GO:0031214,biomineral tissue development,1/10,180/18888,0.0913347640644543,0.0585895160719134,OSR1,1
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,1/10,180/18888,0.0913347640644543,0.0585895160719134,CDH3,1
GO:1905475,regulation of protein localization to membrane,1/10,180/18888,0.0913347640644543,0.0585895160719134,ERBB2,1
GO:0042129,regulation of T cell proliferation,1/10,181/18888,0.0918204735127844,0.0587808831510414,ERBB2,1
GO:0035725,sodium ion transmembrane transport,1/10,182/18888,0.0923059492846812,0.0589213191158409,OSR1,1
GO:0007219,Notch signaling pathway,1/10,183/18888,0.092791191480081,0.0589213191158409,FOXC1,1
GO:0007565,female pregnancy,1/10,183/18888,0.092791191480081,0.0589213191158409,ESR1,1
GO:0045580,regulation of T cell differentiation,1/10,183/18888,0.092791191480081,0.0589213191158409,ERBB2,1
GO:0048736,appendage development,1/10,186/18888,0.0942455176061048,0.0596034894877318,OSR1,1
GO:0060173,limb development,1/10,186/18888,0.0942455176061048,0.0596034894877318,OSR1,1
GO:0000070,mitotic sister chromatid segregation,1/10,188/18888,0.0952139023047899,0.0599740919188911,MYBL2,1
GO:0048771,tissue remodeling,1/10,188/18888,0.0952139023047899,0.0599740919188911,FOXC1,1
GO:0006352,DNA-templated transcription initiation,1/10,189/18888,0.0956977451377822,0.0600377432653876,ESR1,1
GO:0061138,morphogenesis of a branching epithelium,1/10,189/18888,0.0956977451377822,0.0600377432653876,ESR1,1
GO:0006575,cellular modified amino acid metabolic process,1/10,191/18888,0.0966647322694401,0.0604027892981613,TYMS,1
GO:0031503,protein-containing complex localization,1/10,191/18888,0.0966647322694401,0.0604027892981613,ERBB2,1
GO:0002695,negative regulation of leukocyte activation,1/10,192/18888,0.0971478767673437,0.0604637996588731,ERBB2,1
GO:0071897,DNA biosynthetic process,1/10,192/18888,0.0971478767673437,0.0604637996588731,TYMS,1
GO:0071466,cellular response to xenobiotic stimulus,1/10,194/18888,0.0981134681251154,0.06094385305114,NAT1,1
GO:0009755,hormone-mediated signaling pathway,1/10,196/18888,0.0990781299621593,0.061300285951881,ESR1,1
GO:0051650,establishment of vesicle localization,1/10,196/18888,0.0990781299621593,0.061300285951881,CDH3,1
GO:0007051,spindle organization,1/10,197/18888,0.099560112559012,0.0614772348582378,MYBL2,1
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/10,198/18888,0.100041863073934,0.0616533454576207,CDH3,1
GO:0031099,regeneration,1/10,200/18888,0.101004668255307,0.0621246463159574,TYMS,1
GO:0022408,negative regulation of cell-cell adhesion,1/10,203/18888,0.102447137895161,0.062888551020204,ERBB2,1
GO:0044703,multi-organism reproductive process,1/10,204/18888,0.102927498003325,0.06306002139184,ESR1,1
GO:0007623,circadian rhythm,1/10,205/18888,0.103407626724154,0.0631076648859268,TYMS,1
GO:0048469,cell maturation,1/10,205/18888,0.103407626724154,0.0631076648859268,TYMS,1
GO:0001763,morphogenesis of a branching structure,1/10,206/18888,0.103887524156727,0.0631547984469699,ESR1,1
GO:0017148,negative regulation of translation,1/10,206/18888,0.103887524156727,0.0631547984469699,TYMS,1
GO:1902806,regulation of cell cycle G1/S phase transition,1/10,211/18888,0.106283545460929,0.0644864024175034,FAM83D,1
GO:0044706,multi-multicellular organism process,1/10,212/18888,0.106762057242553,0.0645236550002159,ESR1,1
GO:0042098,T cell proliferation,1/10,213/18888,0.107240338428437,0.0645236550002159,ERBB2,1
GO:0045216,cell-cell junction organization,1/10,213/18888,0.107240338428437,0.0645236550002159,CDH3,1
GO:0071383,cellular response to steroid hormone stimulus,1/10,213/18888,0.107240338428437,0.0645236550002159,ESR1,1
GO:2000241,regulation of reproductive process,1/10,214/18888,0.107718389117364,0.0645236550002159,ESR1,1
GO:0045619,regulation of lymphocyte differentiation,1/10,215/18888,0.10819620940808,0.0645236550002159,ERBB2,1
GO:0050866,negative regulation of cell activation,1/10,215/18888,0.10819620940808,0.0645236550002159,ERBB2,1
GO:0051648,vesicle localization,1/10,215/18888,0.10819620940808,0.0645236550002159,CDH3,1
GO:0060348,bone development,1/10,215/18888,0.10819620940808,0.0645236550002159,FOXC1,1
GO:1901654,response to ketone,1/10,217/18888,0.109151159189675,0.0649696303575813,TYMS,1
GO:0007601,visual perception,1/10,219/18888,0.110105188562446,0.065413369600496,CDH3,1
GO:0032412,regulation of monoatomic ion transmembrane transporter activity,1/10,221/18888,0.111058298315026,0.065854885877779,OSR1,1
GO:0043583,ear development,1/10,223/18888,0.112010489235459,0.0661693444190042,OSR1,1
GO:0050953,sensory perception of light stimulus,1/10,223/18888,0.112010489235459,0.0661693444190042,CDH3,1
GO:0000819,sister chromatid segregation,1/10,229/18888,0.114861556875418,0.0675989808410678,MYBL2,1
GO:0022898,regulation of transmembrane transporter activity,1/10,229/18888,0.114861556875418,0.0675989808410678,OSR1,1
GO:0051091,positive regulation of DNA-binding transcription factor activity,1/10,230/18888,0.115335933017294,0.0677510507375389,ESR1,1
GO:0007411,axon guidance,1/10,234/18888,0.117231150332711,0.0684796291270173,ERBB2,1
GO:0034249,negative regulation of amide metabolic process,1/10,234/18888,0.117231150332711,0.0684796291270173,TYMS,1
GO:0097485,neuron projection guidance,1/10,234/18888,0.117231150332711,0.0684796291270173,ERBB2,1
GO:0050670,regulation of lymphocyte proliferation,1/10,237/18888,0.118650164449829,0.0691797084837586,ERBB2,1
GO:0051098,regulation of binding,1/10,238/18888,0.119122712750483,0.0693263712521121,FOXC1,1
GO:0042445,hormone metabolic process,1/10,240/18888,0.120067125331432,0.0696176736039824,ESR1,1
GO:0065004,protein-DNA complex assembly,1/10,240/18888,0.120067125331432,0.0696176736039824,ESR1,1
GO:0032944,regulation of mononuclear cell proliferation,1/10,241/18888,0.120538989807338,0.0697623207663364,ERBB2,1
GO:0060560,developmental growth involved in morphogenesis,1/10,243/18888,0.121482035618762,0.0701786306375712,ESR1,1
GO:0006814,sodium ion transport,1/10,244/18888,0.121953217149672,0.070192291087595,OSR1,1
GO:0043523,regulation of neuron apoptotic process,1/10,244/18888,0.121953217149672,0.070192291087595,MYBL2,1
GO:0007179,transforming growth factor beta receptor signaling pathway,1/10,245/18888,0.122424171227579,0.0703343031151313,CDH3,1
GO:0045930,negative regulation of mitotic cell cycle,1/10,248/18888,0.123835669719139,0.0708855735234409,FOXC1,1
GO:0048738,cardiac muscle tissue development,1/10,248/18888,0.123835669719139,0.0708855735234409,FOXC1,1
GO:1901617,organic hydroxy compound biosynthetic process,1/10,249/18888,0.124305714960706,0.0710250274341683,CDH3,1
GO:0033002,muscle cell proliferation,1/10,251/18888,0.125245124645208,0.07143166917564,FOXC1,1
GO:0045860,positive regulation of protein kinase activity,1/10,257/18888,0.128057914319323,0.0727776906001103,ERBB2,1
GO:0032886,regulation of microtubule-based process,1/10,258/18888,0.128525920376798,0.0727776906001103,ERBB2,1
GO:0045927,positive regulation of growth,1/10,258/18888,0.128525920376798,0.0727776906001103,ERBB2,1
GO:0002221,pattern recognition receptor signaling pathway,1/10,259/18888,0.128993700344389,0.0727776906001103,ESR1,1
GO:0097305,response to alcohol,1/10,259/18888,0.128993700344389,0.0727776906001103,TYMS,1
GO:0009636,response to toxic substance,1/10,260/18888,0.129461254319189,0.0727776906001103,TYMS,1
GO:0010001,glial cell differentiation,1/10,260/18888,0.129461254319189,0.0727776906001103,ERBB2,1
GO:0032409,regulation of transporter activity,1/10,260/18888,0.129461254319189,0.0727776906001103,OSR1,1
GO:0032259,methylation,1/10,262/18888,0.1303956846786,0.0730411917936521,TYMS,1
GO:0044843,cell cycle G1/S phase transition,1/10,262/18888,0.1303956846786,0.0730411917936521,FAM83D,1
GO:0090068,positive regulation of cell cycle process,1/10,263/18888,0.130862561257212,0.0731720485123353,FAM83D,1
GO:0014706,striated muscle tissue development,1/10,265/18888,0.131795637696974,0.073562652245174,FOXC1,1
GO:0009141,nucleoside triphosphate metabolic process,1/10,266/18888,0.132261837751908,0.0736895912861031,TYMS,1
GO:0070663,regulation of leukocyte proliferation,1/10,267/18888,0.132727812492671,0.0736895912861031,ERBB2,1
GO:0071900,regulation of protein serine/threonine kinase activity,1/10,267/18888,0.132727812492671,0.0736895912861031,ERBB2,1
GO:0060828,regulation of canonical Wnt signaling pathway,1/10,268/18888,0.133193562016062,0.0738146919066274,CDH3,1
GO:0003007,heart morphogenesis,1/10,269/18888,0.133659086418846,0.0738146919066274,FOXC1,1
GO:0018108,peptidyl-tyrosine phosphorylation,1/10,269/18888,0.133659086418846,0.0738146919066274,ERBB2,1
GO:0018212,peptidyl-tyrosine modification,1/10,271/18888,0.134589460249465,0.0741978709727881,ERBB2,1
GO:0003018,vascular process in circulatory system,1/10,275/18888,0.136447510716976,0.0750902275044484,FOXC1,1
GO:0090150,establishment of protein localization to membrane,1/10,277/18888,0.137375188898888,0.0753272145355621,ERBB2,1
GO:0140014,mitotic nuclear division,1/10,277/18888,0.137375188898888,0.0753272145355621,MYBL2,1
GO:0002758,innate immune response-activating signaling pathway,1/10,278/18888,0.13783869156457,0.0753272145355621,ESR1,1
GO:0090596,sensory organ morphogenesis,1/10,278/18888,0.13783869156457,0.0753272145355621,OSR1,1
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1/10,279/18888,0.138301970075282,0.0754489466039984,CDH3,1
GO:0043122,regulation of canonical NF-kappaB signal transduction,1/10,286/18888,0.141538651401128,0.0770806252147958,ESR1,1
GO:0010721,negative regulation of cell development,1/10,288/18888,0.142461405586165,0.0774486889805295,ERBB2,1
GO:0051402,neuron apoptotic process,1/10,292/18888,0.144304236408498,0.0783148105076168,MYBL2,1
GO:0009165,nucleotide biosynthetic process,1/10,293/18888,0.144764386851384,0.0784288469806608,TYMS,1
GO:1901293,nucleoside phosphate biosynthetic process,1/10,295/18888,0.145684019693051,0.0787909943167499,TYMS,1
GO:0048562,embryonic organ morphogenesis,1/10,297/18888,0.146602762447873,0.079151414456864,OSR1,1
GO:0002218,activation of innate immune response,1/10,298/18888,0.147061800282068,0.0792628259794831,ESR1,1
GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,1/10,299/18888,0.147520615881701,0.0793737357276282,ERBB2,1
GO:0071560,cellular response to transforming growth factor beta stimulus,1/10,302/18888,0.148895730229461,0.0799764376502875,CDH3,1
GO:0033674,positive regulation of kinase activity,1/10,303/18888,0.149353657846899,0.0800852722237984,ERBB2,1
GO:0051056,regulation of small GTPase mediated signal transduction,1/10,304/18888,0.149811363707622,0.0801936166424851,ERBB2,1
GO:0046651,lymphocyte proliferation,1/10,308/18888,0.151639971492046,0.0809703059980891,ERBB2,1
GO:0071559,response to transforming growth factor beta,1/10,309/18888,0.152096570000392,0.0809703059980891,CDH3,1
GO:1904062,regulation of monoatomic cation transmembrane transport,1/10,309/18888,0.152096570000392,0.0809703059980891,OSR1,1
GO:0007162,negative regulation of cell adhesion,1/10,310/18888,0.152552947324252,0.0809703059980891,ERBB2,1
GO:0030217,T cell differentiation,1/10,310/18888,0.152552947324252,0.0809703059980891,ERBB2,1
GO:0007249,canonical NF-kappaB signal transduction,1/10,311/18888,0.153009103558872,0.0810752362385202,ESR1,1
GO:0032943,mononuclear cell proliferation,1/10,315/18888,0.154831519508601,0.081902534505304,ERBB2,1
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/10,317/18888,0.155741403421774,0.0822451501323564,CDH3,1
GO:0060070,canonical Wnt signaling pathway,1/10,323/18888,0.15846576803403,0.0835432089768084,CDH3,1
GO:1904951,positive regulation of establishment of protein localization,1/10,326/18888,0.159824981026671,0.0841184110666689,ERBB2,1
GO:0006605,protein targeting,1/10,327/18888,0.160277612757612,0.084215337391816,ERBB2,1
GO:1902105,regulation of leukocyte differentiation,1/10,328/18888,0.160730025013009,0.0843118244215396,ERBB2,1
GO:0008202,steroid metabolic process,1/10,329/18888,0.161182217887463,0.0844078744055251,ESR1,1
GO:0048638,regulation of developmental growth,1/10,330/18888,0.16163419147554,0.0845034895784404,FOXC1,1
GO:0030198,extracellular matrix organization,1/10,332/18888,0.162537481170649,0.0846934243554004,FOXC1,1
GO:0045787,positive regulation of cell cycle,1/10,332/18888,0.162537481170649,0.0846934243554004,FAM83D,1
GO:0043062,extracellular structure organization,1/10,333/18888,0.162988797466634,0.0847877483548171,FOXC1,1
GO:0045229,external encapsulating structure organization,1/10,334/18888,0.163439894854149,0.0848816463341518,FOXC1,1
GO:0030111,regulation of Wnt signaling pathway,1/10,342/18888,0.167040804568378,0.0866083684408465,CDH3,1
GO:0042063,gliogenesis,1/10,346/18888,0.168836022965117,0.0872507324089221,ERBB2,1
GO:0043010,camera-type eye development,1/10,346/18888,0.168836022965117,0.0872507324089221,FOXC1,1
GO:0034765,regulation of monoatomic ion transmembrane transport,1/10,349/18888,0.170180150749339,0.0878007010444997,OSR1,1
GO:0070661,leukocyte proliferation,1/10,352/18888,0.171522321910529,0.0883478557243759,ERBB2,1
GO:1990778,protein localization to cell periphery,1/10,356/18888,0.17330884419912,0.0891217179833268,ERBB2,1
GO:0007517,muscle organ development,1/10,359/18888,0.174646459748912,0.0896625807652268,FOXC1,1
GO:0042176,regulation of protein catabolic process,1/10,362/18888,0.175982127105065,0.0902006774635526,FAM83D,1
GO:0045089,positive regulation of innate immune response,1/10,365/18888,0.177315848790193,0.0907360229062892,ESR1,1
GO:0030522,intracellular receptor signaling pathway,1/10,369/18888,0.179091122125711,0.091495207257778,ESR1,1
GO:0090287,regulation of cellular response to growth factor stimulus,1/10,373/18888,0.18086294693461,0.0922501637766601,CDH3,1
GO:0051347,positive regulation of transferase activity,1/10,376/18888,0.182189556028838,0.0927759530016983,ERBB2,1
GO:0051090,regulation of DNA-binding transcription factor activity,1/10,381/18888,0.184396274786911,0.0936679168852539,ESR1,1
GO:0050863,regulation of T cell activation,1/10,382/18888,0.184836974914005,0.0936679168852539,ERBB2,1
GO:1903037,regulation of leukocyte cell-cell adhesion,1/10,382/18888,0.184836974914005,0.0936679168852539,ERBB2,1
GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,1/10,388/18888,0.18747667809025,0.0948523770303813,CDH3,1
GO:0002833,positive regulation of response to biotic stimulus,1/10,390/18888,0.188354868004215,0.095143233604977,ESR1,1
GO:0001654,eye development,1/10,393/18888,0.189670551219434,0.0956537895809633,FOXC1,1
GO:0010959,regulation of metal ion transport,1/10,394/18888,0.190108685552378,0.0957208554441307,OSR1,1
GO:0150063,visual system development,1/10,397/18888,0.191421809626622,0.0962275628689834,FOXC1,1
GO:0001701,in utero embryonic development,1/10,401/18888,0.193169661009444,0.0969508361782135,FOXC1,1
GO:0048880,sensory system development,1/10,403/18888,0.19404231090865,0.0972332413835174,FOXC1,1
GO:0045786,negative regulation of cell cycle,1/10,405/18888,0.194914111260969,0.0975143207517315,FOXC1,1
GO:0140694,non-membrane-bounded organelle assembly,1/10,413/18888,0.198392831897822,0.0990966542164782,MYBL2,1
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,1/10,417/18888,0.200127114024731,0.0998039996307755,CDH3,1
GO:0001558,regulation of cell growth,1/10,418/18888,0.20056015657033,0.0998611974234892,ERBB2,1
GO:0007159,leukocyte cell-cell adhesion,1/10,419/18888,0.200992988104401,0.0999181090251257,ERBB2,1
GO:1903706,regulation of hemopoiesis,1/10,424/18888,0.203153983799683,0.100832590227025,ERBB2,1
GO:0050727,regulation of inflammatory response,1/10,425/18888,0.203585551182807,0.100887160975267,ESR1,1
GO:0042060,wound healing,1/10,430/18888,0.20574023433442,0.101794105647779,ERBB2,1
GO:0030098,lymphocyte differentiation,1/10,432/18888,0.206600637538713,0.102058831307976,ERBB2,1
GO:0045088,regulation of innate immune response,1/10,440/18888,0.210033868222538,0.103591679460967,ESR1,1
GO:0000280,nuclear division,1/10,446/18888,0.212600010326151,0.10469272589803,MYBL2,1
GO:0034329,cell junction assembly,1/10,453/18888,0.215584358973467,0.105995939571182,CDH3,1
GO:0007409,axonogenesis,1/10,455/18888,0.216435158164223,0.106081705810754,ERBB2,1
GO:1901987,regulation of cell cycle phase transition,1/10,455/18888,0.216435158164223,0.106081705810754,FAM83D,1
GO:0051051,negative regulation of transport,1/10,462/18888,0.219406419002175,0.107370248563344,OSR1,1
GO:0016055,Wnt signaling pathway,1/10,466/18888,0.221099725863183,0.10803036285822,CDH3,1
GO:0198738,cell-cell signaling by wnt,1/10,468/18888,0.221945138955554,0.10827478334903,CDH3,1
GO:0043269,regulation of monoatomic ion transport,1/10,470/18888,0.222789726113182,0.108349797440601,OSR1,1
GO:0045859,regulation of protein kinase activity,1/10,470/18888,0.222789726113182,0.108349797440601,ERBB2,1
GO:0043410,positive regulation of MAPK cascade,1/10,475/18888,0.224897585248868,0.109205606003198,ERBB2,1
GO:0022412,cellular process involved in reproduction in multicellular organism,1/10,482/18888,0.227839944561509,0.110292890642186,FOXC1,1
GO:0051345,positive regulation of hydrolase activity,1/10,482/18888,0.227839944561509,0.110292890642186,ESR1,1
GO:1903829,positive regulation of protein localization,1/10,483/18888,0.22825945996705,0.110325714167839,ERBB2,1
GO:1903131,mononuclear cell differentiation,1/10,484/18888,0.228678770230583,0.110358337698322,ERBB2,1
GO:0045785,positive regulation of cell adhesion,1/10,485/18888,0.229097875441282,0.110390762198241,ERBB2,1
GO:0034762,regulation of transmembrane transport,1/10,489/18888,0.230772247537996,0.111027009632423,OSR1,1
GO:0031667,response to nutrient levels,1/10,490/18888,0.231190328820926,0.111057818954842,TYMS,1
GO:0048285,organelle fission,1/10,493/18888,0.232443345914363,0.111318790008004,MYBL2,1
GO:0050808,synapse organization,1/10,493/18888,0.232443345914363,0.111318790008004,ERBB2,1
GO:0016049,cell growth,1/10,496/18888,0.233694524741355,0.111577294517222,ERBB2,1
GO:0022407,regulation of cell-cell adhesion,1/10,496/18888,0.233694524741355,0.111577294517222,ERBB2,1
GO:0002757,immune response-activating signaling pathway,1/10,500/18888,0.235359907795383,0.112031391299455,ESR1,1
GO:0007264,small GTPase-mediated signal transduction,1/10,500/18888,0.235359907795383,0.112031391299455,ERBB2,1
